Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.020
0.00 (0.00%)
Jul 27, 2026, 1:09 PM EST
Nuo Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -2.38 | -2.51 | -2.32 | -3.17 | -3.17 | -0.09 |
Depreciation & Amortization | 0.17 | 0.16 | 0.1 | 0.11 | 0.07 | - |
Stock-Based Compensation | 0.16 | 0.14 | 0.06 | 0.02 | 0.01 | 0.01 |
Provision & Write-off of Bad Debts | 0.08 | 0.09 | 0.08 | 0.16 | - | - |
Other Operating Activities | 0.18 | 0.02 | -0.1 | 0.02 | -0.15 | - |
Change in Accounts Receivable | -0.68 | -0.4 | -0.08 | -0.32 | -0.09 | - |
Change in Inventory | -0.16 | -0.08 | 0.03 | 0.01 | -0.24 | - |
Change in Accounts Payable | -0.28 | 0.22 | -0.04 | -0 | 0.02 | 0.01 |
Change in Unearned Revenue | 1.05 | 1.28 | - | - | - | - |
Change in Other Net Operating Assets | 0.21 | 0.24 | 0.05 | 0.01 | -0.16 | -0.05 |
Operating Cash Flow | -1.65 | -0.86 | -2.23 | -3.17 | -3.71 | -0.12 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.05 | -0.27 | -0.15 | -0.01 | -0.06 | - |
Investing Cash Flow | -0.05 | -0.27 | -0.15 | -0.01 | -0.06 | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 0.5 | - | - | - | - |
Total Debt Issued | 1 | 0.5 | - | - | - | - |
Net Debt Issued (Repaid) | 1 | 0.5 | - | - | - | - |
Issuance of Common Stock | 0.9 | 0.9 | 1.74 | 2 | 4.46 | 1.37 |
Financing Cash Flow | 1.9 | 1.4 | 1.74 | 2 | 4.46 | 1.37 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - | - |
Net Cash Flow | 0.21 | 0.27 | -0.64 | -1.18 | 0.69 | 1.25 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.7 | -1.14 | -2.39 | -3.18 | -3.77 | -0.12 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -41.07% | -34.40% | -174.82% | -521.76% | -3355.12% | - |
Free Cash Flow Per Share | -0.04 | -0.02 | -0.05 | -0.07 | -0.09 | -0.00 |
Levered Free Cash Flow | -1.85 | -1.11 | -1.53 | -1.85 | -2.74 | -0.09 |
Unlevered Free Cash Flow | -1.74 | -1.11 | -1.53 | -1.85 | -2.74 | -0.09 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0 | 0 | 0 | 0 | 0 | - |
Change in Working Capital | 0.15 | 1.24 | -0.04 | -0.3 | -0.47 | -0.04 |